The detailed information for PTAB case with proceeding number IPR2020-00295 filed by AYLA PHARMA LLC against Novartis AG et al. on Dec 24, 2019. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2020-00295
Filing Date
Dec 24, 2019
Petitioner
AYLA PHARMA LLC
Respondent
Novartis AG et al.
Status
Institution Denied
Respondent Application Number
14304124
Respondent Tech Center
1600
Respondent Patent Number
9533053
Institution Decision Date
Aug 6, 2020

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Notice of Refund

Jun 15, 2021PAPERBOARD

Petitioner's Request for Refund of IPR Fees

Jun 8, 2021PAPERPETITIONER

Decision Denying Rehearing Request

May 6, 2021PAPERBOARD

Petitioner's Request for Rehearing

Sep 3, 2020PAPERPETITIONER

Trial Instituted Document

Aug 6, 2020PAPERBOARD

Ex. 3001

Jul 1, 2020EXHIBITBOARD

Patent Owner's Sur-Reply

Jun 19, 2020PAPERPATENT OWNER

Petitioner's Reply To Patent Owner's Preliminary Response

Jun 8, 2020PAPERPETITIONER

EXPUNGED

Jun 5, 2020PAPERPETITIONER

Exhibit 1044 - Telephone Conference Call Transcript

Jun 5, 2020EXHIBITPETITIONER

Updated Exhibit List

Jun 4, 2020PAPERPETITIONER

EXPUNGED

Jun 4, 2020EXHIBITPETITIONER

Patent Owner Preliminary Response

May 15, 2020PAPERPATENT OWNER

Pazeo Prescribing Information

May 15, 2020EXHIBITPATENT OWNER

Declaration of Erning Xia, Argentum Pharm. v. Alcon Research, IPR2016-00544 (PTAB Jan. 31, 2016)

May 15, 2020EXHIBITPATENT OWNER

Day 1 Trial Transcript, Oct. 2, 2017, Alcon v. Watson, No. 15-cv-1159 (D. Del.)

May 15, 2020EXHIBITPATENT OWNER

Petition, Cipla Ltd. v. Alcon Research, IPR2018-01021 (PTAB June 5, 2018)

May 15, 2020EXHIBITPATENT OWNER

Order, Termination of the Proceedings, Cipla Ltd. v. Alcon Research, IPR2018-01020, IPR2018-01021 (PTAB Sept. 17, 2018)

May 15, 2020EXHIBITPATENT OWNER

Dubai Angel Ventures LLC Articles of Organization (Dec. 3, 2019)

May 15, 2020EXHIBITPATENT OWNER

Dubai Angel Ventures LLC Statement of Information (Dec. 30, 2019)

May 15, 2020EXHIBITPATENT OWNER

File History, U.S. Patent 9,533,053

May 15, 2020EXHIBITPATENT OWNER

Declaration of Leonard Bielory, Argentum Pharm. v. Alcon Research, IPR2016-00544 (PTAB Feb. 2, 2016)

May 15, 2020EXHIBITPATENT OWNER

Day 2 Trial Transcript, Oct. 3, 2017, Alcon v. Watson, No. 15-cv-1159 (D. Del.)

May 15, 2020EXHIBITPATENT OWNER

Day 3 Trial Transcript, Oct. 4, 2017, Alcon v. Watson, No. 15-cv-1159 (D. Del.)

May 15, 2020EXHIBITPATENT OWNER

Day 4 Trial Transcript, Oct. 5, 2017, Alcon v. Watson, No. 15-cv-1159 (D. Del.)

May 15, 2020EXHIBITPATENT OWNER

Ayla Pharma LLC Articles of Organization (Nov. 26, 2019)

May 15, 2020EXHIBITPATENT OWNER

Ayla Pharma LLC Statement of Information (Dec. 18, 2019)

May 15, 2020EXHIBITPATENT OWNER

Thompson Capital Holdings LLC Articles of Organization (Nov. 26, 2019)

May 15, 2020EXHIBITPATENT OWNER

Thompson Capital Holdings LLC Statement of Information (Jan. 16, 2020)

May 15, 2020EXHIBITPATENT OWNER

Patent Owner Mandatory Notice Information

Jan 31, 2020PAPERPATENT OWNER

Patent Owner Power of Attorney

Jan 31, 2020PAPERPATENT OWNER

Notice of Accord Filing Date

Jan 17, 2020PAPERBOARD

Petition for Inter Partes Review of U.S. Patent No. 9,533,053

Dec 24, 2019PAPERPETITIONER

U.S. Patent No. 9,533,053 B2 ("'053 Patent")

Dec 24, 2019EXHIBITPETITIONER

YANNI et al., "The In Vitro and In Vivo Ocular Pharmacology of Olopatadine (AL-4943A), an Effective Anti-Allergic/Antihistaminic Agent," Journal of Ocular Pharmacology and Therapeutics, Volume 12, Number 4, 1996, pp. 389-400 ("Yanni")

Dec 24, 2019EXHIBITPETITIONER

U.S. Pat. No. 6,995,186 B2 ("Castillo")

Dec 24, 2019EXHIBITPETITIONER

U.S. Pat. No. 5,641,805 ("Hayakawa")

Dec 24, 2019EXHIBITPETITIONER

Power of Attorney

Dec 24, 2019PAPERPETITIONER

Exhibit List

Dec 24, 2019PAPERPETITIONER

U.S. Patent No. 8,791,154 B2 ("'154 Patent")

Dec 24, 2019EXHIBITPETITIONER

WO 2008/015695 A2 ("Bhowmick")

Dec 24, 2019EXHIBITPETITIONER

U.S. Pat. Pub. No. 2011/0082145 A1 ("Schneider")

Dec 24, 2019EXHIBITPETITIONER

File Wrapper for U.S. Patent No. 8,791,154 B2 (Part 1)

Dec 24, 2019EXHIBITPETITIONER

File Wrapper for U.S. Provisional Appl. No. 61/487,789

Dec 24, 2019EXHIBITPETITIONER

File Wrapper for U.S. Provisional Appl. No. 61/548,957

Dec 24, 2019EXHIBITPETITIONER

Physician's Desk Reference - PATANOL

Dec 24, 2019EXHIBITPETITIONER

David B. Troy, Remington: The Science and Practice of Pharmacy, Philadelphia College of Pharmacy and Science, 21st ed., 229, 856-866 (2005)

Dec 24, 2019EXHIBITPETITIONER

Apotex, Inc. v. Alcon Research Ltd., IPR2016-01640, Paper 2 (P.T.A.B. Aug. 18, 2016)

Dec 24, 2019EXHIBITPETITIONER

Alcon Research, Ltd. v. Watson Labs., 1-15-cv-01159 (D. Del.) Paper 69 (November 18, 2016)

Dec 24, 2019EXHIBITPETITIONER

U.S. Patent No. 6,770,675

Dec 24, 2019EXHIBITPETITIONER

File Wrapper for U.S. Patent No. 8,791,154 B2 (Part 2)

Dec 24, 2019EXHIBITPETITIONER

Handbook of Pharmaceutical Excipients

Dec 24, 2019EXHIBITPETITIONER

Declaration of Dr. Laskar

Dec 24, 2019EXHIBITPETITIONER

Argentum Pharm. LLC v. Alcon Research, Ltd., IPR2016-00544, Paper 8 (P.T.A.B. July 18, 2016)

Dec 24, 2019EXHIBITPETITIONER

Abelson & Gomes, "Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing," Expert Opinion on Drug Metabolism & Toxicology, 4:4, 453-461 (2008) ("Abelson")

Dec 24, 2019EXHIBITPETITIONER

Pharmaceutical Calculations, 13th ed., Ansell, 2010

Dec 24, 2019EXHIBITPETITIONER

Apotex, Inc. v. Alcon Research Ltd., IPR2016-01640, Paper 3 (P.T.A.B. Aug. 18, 2016)

Dec 24, 2019EXHIBITPETITIONER

Abelson et al., "Efficacy of Once-Daily Olopatadine 0.2% Ophthalmic Solution Compared to Twice-Daily Olopatadine 0.1% Ophthalmic Solution for the Treatment of Ocular Itching Induced by Conjunctival Allergen Challenge," Current Eye Research 32:1017-1022

Dec 24, 2019EXHIBITPETITIONER

Leonardi, et al., "The anti-allergic effects of a cromolyn sodium-chlorpheniramine combination compared to ketotifen in the conjunctival allergen challenge model," European J. of Ophthalmology 13(2):128-133 (2003)

Dec 24, 2019EXHIBITPETITIONER

U.S. Patent Publication No. 2008/0085922

Dec 24, 2019EXHIBITPETITIONER

Alcon Research, Ltd. v. Watson Labs., 1-15-cv-01159 (D. Del.) Paper 155 (March 1, 2018)

Dec 24, 2019EXHIBITPETITIONER

Orange Book entry for PAZEO

Dec 24, 2019EXHIBITPETITIONER

EP 0214779

Dec 24, 2019EXHIBITPETITIONER

U.S. Pat. No. 4,871,865

Dec 24, 2019EXHIBITPETITIONER

U.S. Pat. No. 5,116,863

Dec 24, 2019EXHIBITPETITIONER

CV of Dr. Paul Laskar

Dec 24, 2019EXHIBITPETITIONER

Handbook of Chemistry and Physics 2006, 87th ed.

Dec 24, 2019EXHIBITPETITIONER

U.S. Publication No. 2004/0198828 ("Abelson")

Dec 24, 2019EXHIBITPETITIONER

Nandi et al., "NANDI et al., "Synergistic Effect of PEG-400 and Cyclodextrin to Enhance Solubility of Progesterone," AAPS PharmSciTech 2003; 4 (1), pp 1-5."

Dec 24, 2019EXHIBITPETITIONER

Argentum Pharm. LLC v. Alcon Research, Ltd., IPR2016-00544, Paper 1 (P.T.A.B. Feb. 2, 2016)

Dec 24, 2019EXHIBITPETITIONER

Apotex, Inc. v. Alcon Research Ltd., IPR2016-01640, Paper 8 (P.T.A.B. Oct. 5, 2016)

Dec 24, 2019EXHIBITPETITIONER

Apotex, Inc. v. Alcon Research Ltd., IPR2016-01640, Paper 9 (P.T.A.B. Nov. 30, 2016)

Dec 24, 2019EXHIBITPETITIONER

Abelson & Loeffler, Conjunctival Allergen Challenge: Models in the Investigation of Ocular Allergy, Current Allergy and Asthma Reports 3:363-368 (2003)

Dec 24, 2019EXHIBITPETITIONER

Eiichi Uchio, Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops, Clinical Ophthalmology 2(3):525-531, 527-528 (2008)

Dec 24, 2019EXHIBITPETITIONER

https://www.pazeodrops.com/

Dec 24, 2019EXHIBITPETITIONER

EP 0235796

Dec 24, 2019EXHIBITPETITIONER

CV of Dr. S. Craig Dyar

Dec 24, 2019EXHIBITPETITIONER

Declaration of Dr. S. Craig Dyar

Dec 24, 2019EXHIBITPETITIONER

LOFTSSON et al., "Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye," Acta Ophthamologica Scandinavica, 2002, pp. 144-150.

Dec 24, 2019EXHIBITPETITIONER